Literature DB >> 7143352

Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.

R A Glennon, R Young, F Benington, R D Morin.   

Abstract

The serotonin (5-HT) receptor affinities and behavioral (discriminative stimulus) properties of a series of 4-substituted derivatives of 1-(2,5-dimethoxyphenyl)-2-aminopropanes (2,5-DMA) were investigated. The substituents at the 4-position included H, OMe, OEt, Me, Et, F, Br, I, and NO2. Substituent lipophilicities (pi values) of these functionalities appear to have a minimal effect on either 5-HT receptor affinity or behavioral activity. Those derivatives previously found to be most potent in human studies possess significant affinity for 5-HT receptors. Furthermore, when rats trained to discriminate (+/-)-1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) from saline were used, generalization was found to occur upon administration of the 4-substituted 2,5-DMA derivatives. Because a direct relationship exists between the ED50 values obtained from these discrimination studies and human hallucinogenic potencies, the discriminative stimulus paradigm, with DOM as a training drug, appears to be a useful tool for comparing the quantitative and qualitative (DOM-like) effects produced by certain hallucinogenic agents.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143352     DOI: 10.1021/jm00352a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

2.  3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach.

Authors:  Zhuoyong Zhang; Liying An; Wenxiang Hu; Yuhong Xiang
Journal:  J Comput Aided Mol Des       Date:  2007-01-04       Impact factor: 3.686

3.  The structure-activity relationship of inhibitors of serotonin uptake and receptor binding.

Authors:  C Hansch; J Caldwell
Journal:  J Comput Aided Mol Des       Date:  1991-10       Impact factor: 3.686

4.  Regioselective Iodination of Chlorinated Aromatic Compounds Using Silver Salts.

Authors:  Sudhir N Joshi; Sandhya M Vyas; Huimin Wu; Michael W Duffel; Sean Parkin; Hans-Joachim Lehmler
Journal:  Tetrahedron       Date:  2011-09-30       Impact factor: 2.457

5.  Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.

Authors:  W Löscher; U Witte; G Fredow; M Ganter; K Bickhardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

Review 6.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.

Authors:  Adam L Halberstadt; Muhammad Chatha; Stephen J Chapman; Simon D Brandt
Journal:  J Psychopharmacol       Date:  2019-02-21       Impact factor: 4.153

8.  Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.

Authors:  Scott P Runyon; Philip D Mosier; Bryan L Roth; Richard A Glennon; Richard B Westkaemper
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

9.  Blockade of motion- and cisplatin-induced emesis by a 5-HT2 receptor agonist in Suncus murinus.

Authors:  F Okada; H Saito; N Matsuki
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Evaluation of SYA16263 as a new potential antipsychotic agent without catalepsy.

Authors:  Barbara A Bricker; Kwame Peprah; Hye J Kang; S Y Ablordeppey
Journal:  Pharmacol Biochem Behav       Date:  2019-02-12       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.